Top Markets
#1 TENDIES TENDIES +38.63%
#2 Cash Cat Cash Cat +21.63%
#3 OSK OSK +15.52%
#4 Seeker Seeker +12.23%
#5 UnifAI Network UnifAI Network +8.37%
#6 龙虾 (Lobster) 龙虾 (Lobster) +7.87%
#7 Big Time Big Time +6.61%
#8 Tornado Cash Tornado Cash +6.57%
#9 Nesa Nesa +6.14%
#10 ROLL ROLL +5.86%
Coin of the day
TENDIES TENDIES
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Carvolix S.A. Carvolix S.A.

Carvolix S.A.

CVX
Rangering i aksjer #16554
Carvolix S.A. operates as a medical technology firm, concurrently involved in... Carvolix S.A. operates as a medical technology firm, concurrently involved in both commercialization and clinical development, specializing in treatment solutions for structural heart ailments and cerebral strokes. The company's innovative endeavors encompass the creation of AI- and imaging-driven mini-robots, engineered for executing intricate medical procedures, as well as the development of biomimetic heart valves. Established on January 30, 2026, Carvolix S.A. maintains its headquarters in Aix-en-Provence, France.
Aksjekurs
$7.31
Sist synkronisert: 2026-09-01
Markedsverdi
$286.87M
Endring (1 dag)
-1.91%
Endring (1 år)
310.35%
Land
FR
Handel Carvolix S.A. (CVX)

Kategori

Healthcare
Inntekter for Carvolix S.A. (CVX)
Inntekter i Sep 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Carvolix S.A. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Carvolix S.A. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US